I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shore, Neal D.
516
results:
Search for persons
X
Format
Online (516)
Mediatypes
Articles (Online) (270)
OpenAccess-fulltext (246)
Sorted by: Relevance
Sorted by: Year
?
1
Publisher Correction: First-line talazoparib with enzalutam..:
Fizazi, Karim
;
Azad, Arun A.
;
Matsubara, Nobuaki
...
Nature Medicine. 30 (2024) 5 - p. 1505-1505 , 2024
Link:
https://doi.org/10.1038/..
?
2
First-line combination treatment with PARP and androgen rec..:
McKay, Rana R.
;
Morgans, Alicia K.
;
Shore, Neal D.
...
Cancer Treatment Reviews. 126 (2024) - p. 102726 , 2024
Link:
https://doi.org/10.1016/..
?
3
ADVANCED-1: PHASE 1A DOSE-FINDING, OPEN-LABEL STUDY TO EVAL..:
Bandari, Jathin
;
Jayram, Gautam
;
Tabayoyong, William
...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S61 , 2024
Link:
https://doi.org/10.1016/..
?
4
Expert Perspectives on Controversies in Metastatic Castrati..:
Bryce, Alan H.
;
Crawford, E. David
;
Agarwal, Neeraj
...
JU Open Plus. 2 (2024) 4 - p. , 2024
Link:
https://doi.org/10.1097/..
?
5
Pembrolizumab and Enzalutamide in Patients with Abiraterone..:
Yu, Evan Y.
;
Berry, William R.
;
Gurney, Howard
...
European Urology Oncology. 7 (2024) 3 - p. 509-518 , 2024
Link:
https://doi.org/10.1016/..
?
6
EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIE..:
Boorjian, Stephen A.
;
Narayan, Vikram M.
;
Master, Viraj A.
...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S70 , 2024
Link:
https://doi.org/10.1016/..
?
7
Barrigel Spacer Injection Technique:
Gejerman, Glen
;
Goldstein, Martin M.
;
Chao, Michael
...
Practical Radiation Oncology. 14 (2024) 1 - p. e57-e61 , 2024
Link:
https://doi.org/10.1016/..
?
8
Correction: Application of next-generation imaging in bioch..:
Moul, Judd W.
;
Shore, Neal D.
;
Pienta, Kenneth J.
...
Prostate Cancer and Prostatic Diseases. 27 (2024) 2 - p. 358-358 , 2024
Link:
https://doi.org/10.1038/..
?
9
CREST: phase III study of sasanlimab and Bacillus Calmette-..:
Steinberg, Gary D
;
Shore, Neal D
;
Redorta, Joan Palou
...
Future Oncology. 20 (2024) 14 - p. 891-901 , 2024
Link:
https://doi.org/10.2217/..
?
10
Risk Stratification of Patients with Recurrence After Prima..:
Weiner, Adam B.
;
Kakani, Preeti
;
Armstrong, Andrew J.
...
European Urology. , 2024
Link:
https://doi.org/10.1016/..
?
11
A multidisciplinary approach to address unmet needs in the ..:
Shore, Neal D.
;
Antonarakis, Emmanuel S.
;
Ross, Ashley E.
...
Prostate Cancer and Prostatic Diseases. , 2024
Link:
https://doi.org/10.1038/..
?
12
A Model‐Informed Drug Development Approach to Design a Phas..:
Sannala, Chenna Keshava Reddy
;
MacLean, Carol
;
Larsen, Finn
...
Clinical Pharmacology in Drug Development. , 2024
Link:
https://doi.org/10.1002/..
?
13
LONGITUDINAL CHANGES IN PATIENT-REPORTED OUTCOMES (PROs) IN..:
Freedland, Stephen J.
;
Gleave, Martin
;
De Giorgi, Ugo
...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S18 , 2024
Link:
https://doi.org/10.1016/..
?
14
Novel hormone therapy and coordination of care in high-risk..:
Efstathiou, Jason A.
;
Morgans, Alicia K.
;
Bland, Christopher S.
.
Cancer Treatment Reviews. 122 (2024) - p. 102630 , 2024
Link:
https://doi.org/10.1016/..
?
15
Extended Safety and Tolerability of Darolutamide for Nonmet..:
Shore, Neal D
;
Gratzke, Christian
;
Feyerabend, Susan
...
The Oncologist. , 2024
Link:
https://doi.org/10.1093/..
1-15